
Yochi Slonim: Founder and CEO of Anima Biotech
BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima B...
5 Helmi 202241min

Clive Richardson: CEO of Akari Therapeutics
BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari T...
8 Tammi 202232min

Welcome to Season 4 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss s...
28 Joulu 20211min

Stefan König: CEO of George Medicines
BioBoss host John Simboli speaks with Stefan König , CEO of George Medicines, headquartered in London. Hear Stefan’s thoughts about leadership in biopharma and how George Medicines is working to exten...
4 Joulu 202138min

Derek Maetzold: CEO of Castle Biosciences
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of ...
29 Loka 202138min

Bob Cobuzzi: CEO of Diffusion Pharmaceuticals
Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhance...
2 Loka 202134min

Panna Sharma: CEO of Lantern Therapeutics
Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial in...
12 Syys 202139min

Nandan Padukone: CEO of IM Therapeutics
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause...
31 Heinä 202144min




















